Deficiency of ZC3HC1 Modulates Vascular Smooth Muscle Cell Phenotype and Increases Neointima Formation

Area of Science:

• Vascular Biology
• Cellular and Molecular Medicine
• Genetics and Genomics

Background:

• The ZC3HC1 gene is implicated in cardiovascular traits, showing varied effects on coronary artery disease, blood pressure, and carotid intima-media thickness.
• This study investigates ZC3HC1's role in smooth muscle cell (SMC) biology and its influence on neointima formation.

Purpose of the Study:

• To elucidate the function of ZC3HC1 in SMC proliferation and migration.
• To understand ZC3HC1's contribution to neointima formation in response to vascular injury.

Main Methods:

• Analysis of SMC phenotypes (proliferation, migration) based on rs11556924 genotype and ZC3HC1 modulation (knockdown/knockout).
• Transcriptomic profiling and contractile marker analysis to define SMC states.
• In vivo studies using Zc3hc1 knockout mice to assess neointima formation post-injury.
• Immunofluorescence microscopy to determine subcellular localization of NIPA during the cell cycle.

Main Results:

• Reduced ZC3HC1 expression correlated with enhanced SMC migration and proliferation, and CCNB1 accumulation.
• Complete Zc3hc1 knockout in mice led to exaggerated neointima formation and increased SMC migration.
• Complete Zc3hc1 loss paradoxically reduced SMC proliferation and CCNB1 levels, suggesting a dosage-dependent effect.
• ZC3HC1 (NIPA) colocalized with CCNB1 at the cleavage furrow, indicating a role in mitotic exit.

Conclusions:

• ZC3HC1 acts as a dosage-sensitive regulator of SMC phenotype, with partial reduction promoting a synthetic state and complete loss inducing quiescence.
• These findings explain the opposing clinical effects of the rs11556924-T allele and highlight ZC3HC1 as a potential therapeutic target for vascular diseases.